STAT

STAT+: How a tweet about a gene discovered long ago led to a $190 million startup and, maybe, hope for heart disease

A 10-person startup called Marea has raised $190 million to help develop a drug to lower a type of cholesterol and a new way of attacking cardiovascular disease.
A model of the protein known as ANGPTL4.

A 10-person startup called Marea said Tuesday that it had raised $190 million to help develop a drug to lower a

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
STAT+: Don’t Write Off MDMA Yet: How The FDA Got On Board With Psychedelics
Psychedelic evangelists have been working to win over regulators since the 1980s, and those relationships helped persuade the FDA to sign off on research.
STAT1 min read
STAT+: How Controversial Was The Decision By FDA’s Peter Marks To Approve Sarepta’s Gene Therapy? Check Its Footnotes
The unilateral decision by Peter Marks, a top FDA official, to approve a gene therapy for Duchenne muscular dystrophy looks even more surprising on a close examination.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Moderna Covid-flu Vaccine, A Paused Pfizer Study, And More
Moderna announced its combination Covid and flu vaccine generated stronger immune responses in older adults in a Phase 3 trial than individual vaccines.

Related Books & Audiobooks